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Abstract.  Oligodendrocyte-type-2 astrocyte (O-2A) 
glial progenitor cells undergo a limited number of mi- 
totic divisions in response to PDGF before differen- 
tiating  into oligodendroc3,tes, the myelin-forming cell 
of the CNS.  We examined the mechanism limiting 
O-2A proliferation,  and demonstrate that these cells 
secrete an inhibitor of cell proliferation that can be 
neutralized with antibodies to TGF-B.  O-2A cells also 
secrete an inhibitory activity that cannot be neutral- 
ized with TGFo/3 antibodies.  O-2A progenitor cultures 
express TGF-/31 isoform and its transcript,  while 
oligodendrocyte cultures express TGF-B1,/3-2,  and/3-3 
isoforms. Both recombinant TGF-~  and O-2A condi- 
tioned medium inhibit the proliferation of O-2A pro- 
genitor cells cultured in the presence of PDGF, and 
this inhibition can be partially neutralized  with poly- 
clonal TGF-/3 antibodies.  Thus,  TGF-/3 produced by 
O-2A cells may limit PDGF-driven mitosis and pro- 
mote oligodendrocyte development.  TGF-/3 is a less 
potent inhibitor of O-2A proliferation when these cells 
are cultured in the presence of bFGF, suggesting that 
bFGF interferes with TGF-~ signaling.  Thus,  the 
production of TGF-/3 by cells in the O-2A lineage may 
account for the distinct effects of PDGF and bFGF on 
O-2A progenitor cell proliferation.  Moreover, our 
results suggest that TGF-/3 may be an important medi- 
ator of oligodendrocyte differentiation. 
URING vertebrate neural  development,  factors which 
control the cell cycle regulate  the commitment of 
precursor cells into the variety of differentiated neu- 
ronal and glial cell types. Differentiated  cells in the mature 
brain are postmitotic, and are generated from precursor cells 
which arise in the  germinal  subventricular  neural  epithe- 
lium. These precursors retain a remarkable degree of pheno- 
typic plasticity (Gray et al., 1988; Price and Thudow, 1988; 
Turner and Cepko,  1987; Turner  et al.,  1990;  Wetts and 
Fraser, 1988), and commitment to a specific lineage appears 
to be regulated  by signals present in their environment  (Le 
Douarin, 1986; McConnell, 1988; Price, 1989). We have in- 
vestigated the nature of the signals controlling  the prolifera- 
tion and differentiation of a glial precursor cell that generates 
oligodendrocytes, the myelin-forming cell in the central ner- 
vous system (CNS).' 
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oligodendrocyte-type-2  astrocyte; OG, oligodendrocyte;  RT, reverse tran- 
scriptase. 
Oligodendrocytes elaborate multiple processes that  con- 
tact axons and form a compact membranous sheath, the my- 
elin internode,  that facilitates  saltatory axonal conduction. 
Oligodendrocytes arise from precursor ceils that originate in 
the subventricular zone of  the forebrain and the ventral spinal 
cord (Levine and Goldman, 1988; Pringle et al., 1992; Rey- 
nolds and W'ilkin, 1988; Warfet al., 1991). These progenitor 
cells are multipotential  in culture,  forming either oligoden- 
drocytes or type-2 astrocytes under different culture condi- 
tions,  and are termed the oligodendrocyte-type-2 astrocyte 
(O-2A) progenitor cell (Raff  et al., 1983). O-2A progenitors 
persist  in  the  adult  CNS,  where  they  are  termed  the 
O-2A  ~ault progenitor cell (Wren et al.,  1992). 
In culture,  O-2A progenitor cells proliferate in response 
to several polypeptide growth factors,  including  basic FGF 
and PDGF, and differentiate  into postmitotic oligodendro- 
cytes upon withdrawal  of mitogens (Raft,  1989).  FGF is 
mitogenic for oligodendrocyte precursor cells (Besnard  et 
al.,  1989;  B6gler et al.,  1990;  Eccleston and Silberberg, 
1985;  McKinnon et al.,  1990; Noble et al.,  1988; Saneto 
and  de  Vellis, 1985).  FGF  also  blocks  oligodendrocyte 
differentiation,  by maintaining  O-2A progenitors in the cell 
cycle, and sensitizes  these cells to PDGF, by upregulating 
their PDGF receptors (McKinnon  et al.,  1990).  PDGF, in 
turn,  induces  a bipolar state associated with cell motility, 
and is chemotactic for O-2A progenitor cells (Armstrong  et 
al., 1990; B6gler et al., 1990; McKinnon et al., 1993; Noble 
et al.,  1988;  Small et al.,  1987). 
While PDGF is mitogenic for O-2A progenitor cells (No- 
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tinct from bFGF in that PDGF triggers only a limited num- 
ber of divisions before differentiation (Raft et al., 1988). The 
normal in vivo timing of oligodendrocyte differentiation can 
be  reconstituted in O-2A cultures in vitro by addition of 
type-1 astrocytes, type-1 astrocyte-conditioned medium, or 
PDGF which is produced by astrocytes in vitro (Noble and 
Murray,  1984;  Raft et al.,  1985, 1988;  Richardson et al., 
1988).  Thus, PDGF is said to drive a "clock" regulating the 
timing of oligodendrocyte development in vitro (Raft et al., 
1988). PDGF is produced by both astrocytes and by neurons 
in vivo (Sasahara et al.,  1991; Yeh et al., 1991), indicating 
that interactions between these cell types may regulate the 
timing of oligodendrocyte development in vivo. 
O-2A progenitor ceils in culture have been shown to pro- 
duce molecules which inhibit their own proliferation (Louis 
et al.,  1992b)  and promote oligodendrocyte differentiation 
(Levi et al., 1991), suggesting that their differentiation may 
be induced by factors acting in either an autocrine or para- 
crine  manner.  We  have  examined whether  these  signals 
could be related to the TGF-/3 family of molecules, which in- 
cludes five members with a high degree of sequence conser- 
vation (TGF-ffs 1-5)  with significant homology to an ex- 
tended  superfarnily  of molecules  including  the  activins, 
inhibins,  Miillerian inhibiting substance, decapentaplegic, 
bone morphogenic factors, and vgl (Massagut, 1990; Miller 
et al.,  1989b).  The TGF-ffs are produced by glial cells in 
vitro and in vivo (da Cunha et al., 1993; da Cunha and Vit- 
kovit, 1992; Flanders et al., 1991), have both inductive and 
inhibitory activities on cell proliferation, and are important 
regulators of differentiation in a  variety of systems (Mas- 
sagut, 1990; Roberts and Sporn, 1990; Sporn et al., 1987). 
In this study, we demonstrate that cultured O-2A lineage 
cells express transcripts encoding specific isoforms of the 
TGF-ffs, that these proteins can be detected in cultured cells 
by immunostaining, and that these calls secrete into their 
culture medium a growth inhibitory activity that can be neu- 
tralized with antibodies to TGF-/3. Both recombinant TGF- 
/31 and O-2A conditioned media can inhibit the proliferation 
of O-2A progenitor cells in response to PDGE The ability 
of TGF-j3 to inhibit bFGF-driven proliferation of O-2A cells 
is significantly reduced. Our results may account for the dis- 
tinct effects of bFGF and PDGF on O-2A progenitor cell 
proliferation, and suggest that TGF-/3 could be either an au- 
tocrine or paracrine mediator of oligodendrocyte differenti- 
ation. 
Materials and Methods 
Primary Glial Cell Culture 
Primary cortical glial cultures were established from 2-d old Sprague- 
Dawley rat pups (Taconic Farms Inc., Germantown, NY) as previously de- 
scribed (Behar et al.,  1988),  and were  maintained in DMEM  (4.5  g/L 
~glucose) supplemented with 25 ~g/ml gentamycin and 10% FBS (Hy- 
clone Labs., Logan, UT). Optimal growth was obtained by refeeding every 
3 d and by using sera which was not heat inactivated.  O-2A progenitor ceils 
were isolated from monolayer cultures after 8-10 d by shaking on a rotary 
platform (180 rpm) at 37°C overnight (McCarthy and de Vellis, 1980), and 
enriched to >95 % purity of O-2A progenitor cells by reverse panning of 
cells coated with monoclonal antibody A2B5 ascites fluid (Behar et al., 
1988). Ceils were plated at 140~100 ceils per 12-mm poly-L-lysine-coated 
coverslip (Bellco Glass, Inc., Vineland, NJ), or 2  ×  106 cells per 100-ram 
Falcon dish, in DMEM with 10% FBS. After 18 h the cultures  were refed 
with control medium (DMEM supplemented with 50 #g/ml transferrin, 30 
nM sodium selenite,  30 nM triiodothyronine, 50 ng/ml bovine insulin, and 
0.5 % FBS) (Eccleston and Silberberg, 1984), plus 5 ng/ml bFGF or 5 ng/ml 
PDGF-AA (Upstate Biotechnology, Inc., Lake Placid, NY). Growth factors 
were replenished every 36-48 h. 
Immunocytochemistry 
Cells growing on glass coverslips were fixed in 2 % paraformaldehyde,  and 
then processed for immtmocytochemistry  as described (Behar et al., 1988). 
Antibodies for glial lineage analysis  included monoclonals A2B5 (Eisen- 
barth et al., 1979), O1 and 04 (Sommer and Scbachner,  1981), and RmAb 
(Ranscht et ~.,  1982). A2B5 and 04 recognize surface antigens expressed 
during progdnitor cell maturation (Bansal et al.,  1989;  Dubois-Daleq, 
1987; Gard and Pfeiffer, 1990). The O1 antibody is specific for the oligoden- 
drocyte differentiation marker galactocerebroside  (G-C) (Raft et al., 1978), 
while RmAb recognizes  GC, sulfatide,  and related glycolipids  (Bansal et 
al.,  1989). 
For TGF-/3 immunoreactivity,  ceils were fixed in Bouin's fixative for 20 
min, and then with methanol (-200C,  10 rain), and then blocked in 10% 
normal goat sera for 30 min. TGF-/3 antibody staining was done using 10 
#g/ml rabbit anti-TGF-/3 antibody (R&D Sys., Inc., Minneapolis, MN), 20 
#g/ml turkey anti-TGF-B1 antisera (Genzyme Corp., Cambridge, MA), or 
2 #g/ml affinity purified rabbit anti-TGF-/52 and -/33 antipeptide antisera 
(Flanders et al., 1991) provided by Kathy Flanders and Anita Roberts, Na- 
tional Cancer Institute.  Cells on glass coverslips were incubated with pri- 
mary antibodies at room temperature for 60 min, and TGF-/3 immuno- 
reactivity was detected by incubating the coverslips  for 60 min with 15 
#g/ml  of appropriate  secondary  antibody,  either donkey  anti-rabbit Ig 
(Amersham Corp., Arlington Heights,  IL) or rabbit anti-turkey  IgG (Zy- 
med Labs, Inc., S. San Francisco, CA) antibodies conjugated to biotin, fol- 
lowed by incubation for 30 min with 1:1,000 dilution of peroxidase  con- 
jugated streptavidin  (Zymed Labs., Inc.). Peroxidase activity was detected 
using an aminoethyl carbazole substrate kit (Zymed Labs.,  Inc.) as de- 
scribed by the manufacturer.  No immunoreactivity was detectable when 
cells under any of the culture conditions were incubated in absence of pri- 
mary antibodies.  Coverslips  were  mounted on glass slides  using Flnro- 
mount-G (Southern Biotech, Inc.,  Birmingham, AL) and photographed 
with Kodak  400  ASA  Tri-X  film under phase-contrast and bright-field 
optics. 
RT-PCR Analysis 
RNA was  extracted from cultured cells in the presence of guanidinium 
isothiocyanate,  and then isolated by centrifugation through CsC1 (Chirgwin 
et al.,  1979).  Reverse transcriptase (RT) reactions were performed using 
10 ~g total cell RNA and 20 pmol d(T)15 as described (McKinnon et al., 
1993). RNA plus primers were heated at 95°C for 3 min, annealed at 37°C 
for 5 rain, and then at room temperature for 5 rain, and then incubated at 
37°C for 60 rain in 20 #1 of 10 mM Tris hydrochloride (pH 8.3), 50 mM 
KCI-1.5 mM MgCl2, 1 mM deoxynucleoside  triphosphates and 1.5 U/#I of 
Moloney MuLV-RT (Stratagane Inc., San Diego, CA). Reactions were ter- 
minated by heating at 95"C for 10 rain. PCR contained 150 pmol of primer 
pairs and 2 #1 (,x,1 #g) of eDNA in 50 #1 of 10 mM Tris hydrochloride  (pH 
8.3),  50 mM KC1, 1.5 mM MgCIz, 0.4 mM dNTPs, and .05 U/#I of Taq 
DNA polymerase (Perkin-Elmer,  Norwalk,  CT), and subjected to 30 cycles 
at 94"C for 1.5 min, 55"C for 1.5 rain, 72°C for 3 rain using a DNA ther- 
mocycler (Perkin Elmer). DNA fragments were resolved by electrophoresis 
on 4-20% acrylamide gradient gels (Novex,  San Diego,  CA). 
Oligonucleotide  primers were synthesized  on a 380A DNA synthesizer 
(Applied Biosystems,  Inc., Foster City, CA). Primers were based on pub- 
lished nucleotide sequences for rat TGF-B1 (Qian et al., 1990), mouse TGF- 
/32 (Miller et al., 1989a),  human TGF-B2 (de Martin et al.,  1987), mouse 
TGF-/33 (Denhez et al., 1990), human TGF-/33 (ten Dijke et al., 1988), and 
rat cyclophilin  clone IB15 (Danielson et al.,  1988). "I'GF-13  primers were 
selected using the PCR primer selection program (Lowe et al.,  1990). To 
optimize their utility, primers were selected  from regions with maximal 
conservation between the published sequences for rodent and human TGF-/3 
isoforms using the GAP alignment program of the Sequence Analysis Soft- 
Version  5  (University of Wisconsin Genetics Computer  ware  Package, 
Group,  Madison, Wisconsin). 
DNA Sequence Analysis 
The identity of the PCR products amplified by TGF-/32 and TGF-/33 primer 
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TGF-B in primary O-2A cell 
cultures.  (Left panels) O-2A 
progenitor  cells  cultured  in 
the  presence  of  bFGF  and 
PDGE  (Right panels) oligo- 
dendrocyte  cultures.  Cells 
were  immunostained with (A 
and B) turkey anti-TGF-B1; (C 
and  D)  rabbit  anti-TGF-B2; 
and  (E  and  F)  rabbit  anti- 
TGF-/~3 antisera. C and E  are 
phase-contrast  photomicro- 
graphs  in order  to  show  the 
presence  of  unstained  cells; 
all  other  panels  are  bright- 
field  photographs.  Bar,  20 
#M. 
pairs were confirmed by direct DNA sequencing analysis.  PCR products 
were purified using Gene Clean (BIO 101, San Diego, CA) and used as tem- 
plates for asymmetric PCR amplification (MeCabe, 1990). The asymmetric 
products were  dialyzed  (Centricen filters; W.  R.  Grace &  Co.-Conn., 
Beverley,  MA),  ethanol precipitated,  and then sequenced using the Se- 
quinase II protocol (Un. States Biochem. Corp., Cleveland, Oil). Sequenc- 
ing products were resolved by electrophoresis on 6% polyacrylamide-urea 
gels which were fixed in 10% acid/methanol before drying, and then ex- 
posed to Kodak XAR-5 film. The DNA sequences shown represent partial 
coding regions of TGF-ff2 and TGF-B3, and were done twice on PCR frag- 
ments generated in separate reactions from eDNA of adult rat brain. 
Detection of TGF-B Activity from Conditioned 
Culture Medium 
Growth inhibitory activity in conditioned media (CM) were determined 
using CCL-64 mink lung cells (Danielpour et al., 1989) or primary O-2A 
progenitor cells.  CCL-64 proliferation assays were carried out in 24 well 
plates  (Costar  Corp.,  Cambridge,  MA)  containing  105  cells/well,  in 
medium containing 0.5 % FBS. Cells were incubated either in the presence 
of TGF-/~I or CM  for 26 h,  with 0.5  /zCi [3H]thymidine  (Amersham, 
specific activity 48 Ci/mmol) present for the final  4 h, and then incorporated 
radioactivity was determined by liquid scintillation counting as described 
(Danielpour et al.,  1989).  TGF-B standard curves were performed in the 
same medium using recombinant human TGF-/~I and TGF-/~2 (R&D Sys., 
Inc.). All points were done in triplicate, and results are presented as mean 
+  SEM. 100% incorporation represents thymidine incorporation in the ab- 
sence of inhibitors. O-2A proliferation assays were carried out in either 24 
well (105 cells/well)  or 96 well (104 cells/well)  plates.  Cells were incubated 
in control culture medium (described above) plus indicated growth factors 
for 24 h, with [3H]thymidine present for the final 7 h. 100% incorporation 
represents the thymidine incorporation in growth factor-treated cultures in 
absence of inhibitors. 
CM were collected from primary O-2A cells plated in 100-ram dishes 
as described above. After 18 h in DMEM plus  10% FBS,  the cells were 
refed with control culture medium in absence of growth factors,  and CM 
were collected every 24 h. The first 24-h CM represented O-2A progenitor 
cell CM (O2A-CM),  after which the cells acquired the complex morphol- 
ogy of differentiated  oligodendroeytes  (OG-CM).  The CM were filtered 
(.45/z), BSA (1/~g/ml) and protease inhibitors (1/~g/ml each of leupeptin, 
pepstatin, and aprotinin) were added (Sigma Chemical Co., St. Louis, MO) 
and the media were stored at -20°C.  To activate  latent forms of TGF-~, 
the CM were transiently acidified  (10 min at pH 2.0), and then neutralized 
immediately  before use as described (Danielpour et al.,  1989).  Transient 
acidification  of control medium had no effect on assays with recombinant 
TGF-~I  standards. 
Antibody Neutralization 
Four anti-TGF-B neutralizing antibodies have been used in this study, in- 
eluding a rabbit polyclonal  anti-TGF-/~(l,2,3) neutralizing antibody (R&D 
Sys.,  Inc.),  a mouse monoelonal anti-TGF-B(1,2,3)  antibody (Genzyme, 
Inc.),  and turkey  antisera (Danielpour et al.,  1989)  raised against and 
specific for TGF-B1 and TGF-/52 (generously provided by Dr. Anita Roberts, 
National Cancer Institute).  Neutralizations were carded out by preincuba- 
tion of either recombinant  TGF-B or CM with antibodies for 30 min at room 
temperature. 
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Expression of TGF-~ Isoforms during 
Oligodendrocyte Differentiation 
The TGF-/3s have potent inhibitory effects on the prolifera- 
tion of a variety of cell types (Massagu6, 1990; Sporn et al., 
1987; Roberts and Sporn,  1990).  Three isoforms of TGF-/3 
have been characterized in mammalian cells, TGF-/31, TGF- 
/32, and TGF-fl3. We used isoform-specific TGF-/3 antisera 
(Flanders et al.,  1991) to determine whether the inhibitory 
activities produced by O-2A lineage cells (Levi et al., 1991; 
Louis et al.,  1992b) could be related to one of these forms 
of TGF-fl. As shown in Fig.  1, both O-2A progenitor cells 
and oligodendrocytes had detectable immunoreactivity with 
anti-TGF-/31 antisera (Fig. 1, A and B). Similar results were 
obtained with rabbit antisera recognizing all three isoforms 
of TGF-/3 (data not shown). The immunostaining was pri- 
marily cytoplasmic and perinuclear (Flanders et al., 1989). 
O-2A progenitor cells cultured in the presence of  bFGF plus 
PDGF had no detectable immunoreactivity with TGF-/32 or 
TGF-B3 antisera (Fig. 1, C and E). Similar results were ob- 
tained with freshly isolated O-2A progenitor cells which had 
not been exposed to these growth factors (data not shown). 
In contrast, cultured oligodendrocytes were immunopositive 
with both TGF-B2 (Fig. 1 D) and TGF-/33 (Fig. 1 F) antisera. 
We also examined the expression of TGF-/~ transcripts in 
O-2A cultures, using isoform-specific oligodeoxynucleotide 
primers (Fig. 2 a) to detect TGF-/3 transcripts by PCR am- 
plification.  RNA  was  isolated  from cells  growing under 
different culture conditions, reverse transcribed into cDNA 
using oligo(dT) as a  primer,  and then amplified by PCR 
using specific TGF-B primer pairs. The predicted PCR prod- 
ucts of 315, 373, and 536 bp for TGF-~, TGF-/$2, and TGF- 
B3, respectively, were detected after PCR amplification of 
rat brain cDNA (Fig. 3, lane 1 ). Digestion of the rat TGF-~ 
PCR product with PstI endonuclease generated restriction 
fragments of 250 and 65 bp (data not shown), as predicted 
from the DNA sequence (Qian et al., 1990).  The identity of 
the rat TGF-/32 and TGF-B3 PCR products, generated using 
primers corresponding to conserved regions of mouse and 
human TGF-/3 sequences, were confirmed by direct DNA se- 
quence analysis (Fig. 2 b). For TGF-/~2, the sequenced re- 
gion was 93 and 91% homologous to mouse and human TGF- 
B2, respectively. For TGF-B3, the rat sequence was 95 and 
88%  homologous to  mouse and human TGF-B3,  respec- 
tively. For TGF-B2, there were five amino acid substitutions 
and for TGF-B3 there was one change relative to the human 
sequence (Fig. 2 b). 
These TGF-B isoform-specific primer pairs were used to 
examine the  expression  of TGP-/3 transcripts  in cultured 
O-2A lineage cells, as shown in Fig. 3. O-2A progenitor ceils 
maintained in the presence of bFGF expressed only TGF-B1 
transcripts (Fig. 3, lane 3), while oligodendrocyte cultures 
expressed  transcripts  encoding  all  three  TGF-/3 isoforms 
(Fig. 3, lane 4), in agreement with the immunohistochemi- 
cal analysis shown in Fig.  1. The additional PCR products 
seen with the TGF-/32 primer pairs in oligodendrocyte cul- 
tures, which were not seen in rat brain cDNA using the same 
primer pairs, have not been characterized. For comparison, 
we also examined the expression of TGF-B transcripts in cul- 
tured type-1 astrocytes, a macroglial cell type that is distinct 
from the O-2A lineage. As predicted by immunohistochemi- 
Figure 2.  (a)  Isoform-specific primer  pairs for  reverse tran- 
scriptase-PCR (RT-PCR) analysis of TGF-B transcripts in O-2A 
lineage cells. Numbers refer to the  5' nucleotide positions for 
rat  TGF-~I and mouse TGF-B2 and TGF-/33 primers, and the 
predicted size of  each PCR product in bp. Arrows indicate the posi- 
tion of each primer relative to the coding regions for precursor 
(boxed) and active peptide (shaded box) TGF-/3 isoforms. (b) Se- 
quence of rat TGF-/5~2 and -/33 PCR products generated from rat 
brain by RT-PCR. Numbers in parentheses refer to corresponding 
positions of the published sequence  of mouse TGF-/T2 and TGF-B3, 
and the start of the mature TGF-/T2 is underlined. The translated 
amino acid sequence is shown above, with positions differing from 
human shown in bold. The nucleotide sequence of murine and hu- 
man TGF-B2 and/33 (variant positions only) are shown below the 
rat sequence. These sequence data are available from EMBL/Gen- 
Bank/DDBJ under accession numbers X71904 (rat TGF-B2) and 
X71903 (rat TGF-/33). 
cal analysis (Saad et al.,  1991), these cells expressed tran- 
scripts encoding TGF-/32 (Fig. 3, lane 2). We did not detect 
TGF-/31 transcripts in type-1 astrocytes (da Cunha and Vit- 
kovi6,  1992) cultured under these conditions. 
O-2A Lineage Cells Release TGF-B into Their 
Culture Medium 
We used the sensitive CCL-64 proliferation inhibition assay 
(Danielpour et al., 1989) to determine whether the TGF-Bs 
made by O-2A lineage cells were secreted into their culture 
medium. As shown in Fig. 4, conditioned medium from both 
primary O2A progenitor cells and from oligodendrocytes 
The Journal of Cell Biology, Volume 121,  1993  1400 Figure 3.  Expression of TGF-# transcripts in O-2A lineage cells. 
RT-PCR analysis of RNA (1 tzg each) from adult rat brain (lane 1 ), 
cultured type-1 astrocytes (lane 2), O-2A progenitor cells (lane 3), 
and oligodendrocytes  (lane 4). RNA was reverse transcribed into 
cDNA, amplified using TGF-/~ isoform-specific  primer pairs, and 
then the DNA products were resolved  by electrophoresis on 4-20 % 
acrylamide gels and visualized after ethidium bromide staining. 
Shown are the regions of the gels with detectable PCR products. 
DNA sizes are in bp. 
contained an activity which produced a dose-dependent inhi- 
bition of  CCL-64 mink lung epithelial cell proliferation. The 
inhibitory activity of 50 %-CM was equivalent to that of 400 
pg/ml recombinant TGF-~I. The majority of the inhibitory 
activity present in both O2A-CM and OG-CM was neutral- 
ized by preincubation with rabbit anti-TGF/$ serum (Table I). 
This serum, raised against recombinant TGF-/$ and capable 
of neutralizing all three isoforms of TGF-/$, neutralized 90 % 
of the activity of 500  pg/ml recombinant human TGF-fll 
when used at a concentration of  20 #g/ml (Table I). With four 
independent preparations of OG-CM, this serum neutralized 
from 51 to 85 % of the CCL-64 inhibitory activity present. 
Comparable results were obtained with a monoclonal anti- 
TGF-/$(1,2,3) neutralizing antibody (data not shown). Thus, 
the major CCL-64 inhibitory activity present in these glial 
CM represent a form of'l'GF-/$ recognized by these specific 
antibodies. 
We also used isotype-specific neutralizing antisera (Dan- 
ielpour et al.,  1989) to examine whether different isoforms 
of TGF-/$ were secreted into the O-2A culture medium. The 
specificity of these antisera was determined using recom- 
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Figure 4. Inhibition of CCL64 proliferation with glial cell condi- 
tioned medium. Incorporation of [3H]thymidine  into CCL64 mink 
lung epithelial  cells, cultured for 24 h in the presence of  conditioned 
medium collected from cultures of O-2A progenitor cells (O2A- 
CM, open symbols) and oligodendrocytes (OG-CM, closed sym- 
bols). The CM was transiently acidified in order to activate any 
latent TGF-~. Values represent the mean + SEM of triplicate sam- 
pies, and are representative of four independent assays. 100% in- 
corporation (DMEM+0.5%  FBS, in absence of CM) represents 
62,328 5:2,883 cpm. 
binant TGF-~I and TGF-/$2. Polyclonal turkey anti-TGF-~l 
antisera  neutralized  recombinant  TGF-/5'I with  no  cross- 
reactivity with TGF-/$2, anti-TGF-/$2 antisera had the oppo- 
site reactivity, and monoclonal anti-TGF-/$(1,2,3) antibody 
neutralized all isoforms of TGF-/3 (Fig. 5). Using these re- 
agents, CM from O-2A progenitor cell cultures were par- 
tially neutralized with both anti-TGF-/$1 and with anti-TGF- 
/$2 sera (Fig. 5). The activity present in oligodendrocyte  CM 
was partially neutralized with anti-TGF-/$2 but not anti-TGF- 
fll antisera (Fig.  5).  Anti-TGF-/$(1,2,3)  antibody gave the 
best neutralization of OG-CM (Fig. 5), suggesting that both 
TGF-/$2 and TGF-/$3 isoforms are released into oligoden- 
drocyte-conditioned medium. 
O-2A Lineage Cells also Secrete an Inhibitory Activity 
That Is Not Neutralized by TGF-/$  Antibodies 
The TGF-/$'s are secreted from cells in a latent form, requir- 
ing proteolytic processing in order to be biologically active 
(Roberts and Sporn,  1990; Massagu6, 1990).  To determine 
if inhibitory activities other than latent forms of TGF-/$ were 
produced by O-2A lineage cells, we examined CM both with 
and without prior transient acidification (Fig. 6). O-2A pro- 
genitor cells were cultured without mitogens, allowing the 
cells to differentiate into oligodendrocytes, and conditioned 
medium was collected every 24 h for 6 d. Acidified CM col- 
lected from day 1 cultures (O2A-CM) gave 86%  inhibition 
McKirmon et al.  TGF-[3 Promotes Oligodendrocyte Differentiation  1401 Table L Neutralization of CCL-64 Growth Inhibitory Activity with TGF-f3  Antibody 
Thymidine incorporation,  cpm 
(% control) 
- Antibody  + Antibody 
TGF-#I pg/ml 
0  22,533  +  8,877  (100%)  - 
100  11,822  +  2,212  (52%)  22,993  +  2,584(102%) 
250  6,445  +  29  (28.6%)  24,067  +  2,180 (107%) 
500  1,666  +  671  (7.4%)  9,068  +  185  (87%) 
Conditioned  medium 
Expt.  1 O2A-CM  6,015  +  314  (27%)  16,811  +  1,977  (75%) 
OG-CM  5,279  +  226  (23%)  16,589  +  1,211  (74%) 
Expt.  2  O2A-CM  4,219  +  442  (23%)  8,099  +  789  (44%) 
OG-CM  718  +  29  (4%)  11,199  +  132  (61%) 
Expt.  30G-CM  645  -I- 123  (6.7%)  8,452  +  417  (88%) 
Expt. 40G-CM  3,097  +  1,309  (10%)  22,477  +  1,548  (73%) 
Inhibition of CCL-64 proliferation  by recombinant  TGF-~I and by conditioned  medium from O-2A progenitor  cells and oligodendrocytes.  The CM (100% vol) 
was transiently  acidified  to activate latent TGF-~ activity, and then preincubated  in the presence  or absence of 20 t~g/ml rabbit anti-TGF-#(1,2,3)  neutralizing 
antisera. Results  are expressed  as the mean + SD of [3H]thymidine  incorporation  (cpm) in triplicate  samples,  and values in parentheses represent  percent  control 
thymidine incorporation  in CCL-64 cells in the absence of CM. 
of  CCL-64  cell  proliferation,  equivalent  of  1,000  pg/ml 
TGF-/~ activity. There was a  relatively constant level of in- 
hibitory activity in acidified CM from day 2 through 6 (OG- 
CM) in these cultures (Fig. 6, closed symbols). In day 1 cul- 
tures,  ,050%  of this activity was  detectable without prior 
acidification of the CM  (Fig. 6, open symbols).  The levels 
of inhibitory activity in nonacidified CM decreased after day 
1  (Fig. 6,  open symbols),  coincident with oligodendrocyte 
differentiation. 
To determine if the activity present in nonacidified condi- 
tioned medium from O-2A progenitor cell (day 1) cultures 
was a form of TGF-/~, we attempted to neutralize this activity 
using anti-recombinant TGF-/~ antibodies. As shown in Table 
II, the activity present in nonacidified CM was not affected 
by preincubation with TGF-/~ antibodies. Incubation of acid- 
Figure 5. Neutralization of CCL-64 growth-inhibitory activities in 
conditioned medium from O-2A progenitor cells (02A-CM) and 
oligodendrocytes (OG-CM). The CM (100%  vol) was transiently 
acidified to activate latent TGF-/~ activity, and then preincubated in 
the presence or absence of turkey anti-TGF-ffl (stippled bars), tur- 
key anti-TGF-/~2 (striped bars), or mouse monoclonal anti-TGF- 
/~(1,2,3) neutralizing antibodies (open bars). (rTGF-f31, rTGF-f32) 
recombinant TGF-~I and -/~2. Results are the average (+  SEM) 
from two independent experiments in triplicate, and are expressed 
as percent of control [3H]thymidine incorporation in CCL-64 cells 
in absence of CM.  100%  incorporation represents 46,029  +  270 
cpm. 
treated CM with these antibodies reduced the level of total 
inhibitory activity to  that  of nonacidified CM  (Table II). 
Thus, there are two inhibitory components present in O2A- 
CM.  One  (latent TGF-~) is seen upon acidification of the 
CM and is neutralized by anti-TGF-/~ antibodies. A  second 
component active in nonacidified CM cannot be neutralized 
with these antibodies. This second activity could represent 
a  modified form of TGF-/~, distinct from the recombinant 
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Figure 6.  Levels of total and latent TGF-fl inhibitory activity in 
O-2A culture medium. Inhibition of proliferation of CCL64 cells 
with conditioned medium, collected every 24 h over a 6-d period, 
from O-2A cultures. Conditioned medium (100% vol) was assayed 
both with (closed symbols) and without (open symbols) acidifica- 
tion in order to detect total inhibitory activity present and inhibi- 
tory activities other than latent TGF-~, respectively. Results repre- 
sent the mean +  SEM of triplicate samples from one experiment, 
and were repeated in two separate assays.  O-2A progenitor cells 
were undifferentiated at day 1, and began to acquire the phenotype 
of differentiated oligodendrocytes by day 2-3  in these cultures. 
100%  incorporation represents 62,328  +  2,883  cpm. 
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Cannot be Neutralized by TGF-fl Antibody 
Thymidine incorporation 
(% control) 
-  Antibody  + Antibody 
Untreated CM  74.4  4- 4.9  72.9  4-  .52 
Acid-treated CM  30.4  4-  5.0  68.1  4-  4.4 
Inhibition of CCL-64 proliferation by O2A-CM (100%  vol), preincubated in 
the presence and absence of monoclonal anti-TGF-#(1,2,3) neutralizing anti- 
body. Acid-treated CM: CM was transiently acidified to activate latent TGF-~ 
activity. Results are expressed as the mean +  SEM of [3H]thymidine incorpo- 
ration in triplicate samples, expressed as percent of control incorporation (in 
DMEM+0.5%  FBS) in absence of CM (52,404  5:789 cpm). 
TGF-fls used to raise these neutralizing antibodies, or could 
represent an inhibitory molecule that is distinct from TGF-fl. 
TGF-[31 Inhibits O-2A Progenitor Cell Proliferation 
and Promotes Oligodendrocyte  Differentiation 
O-2A progenitor cells have a limited proliferative capacity 
when cultured in the presence of PDGF (Raft et al.,  1988). 
We examined whether the production and accumulation of 
TGF-/~ in their culture media could account for this limited 
proliferation. O-2A progenitor cells were cultured with in- 
creasing concentrations of either recombinant TGF-~I (Fig. 
7 a) or oligodendrocyte-conditioned  medium (Fig. 7 b), and 
the incorporation of thymidine was determined after 24 h. 
The level of DNA synthesis in O-2A progenitor cells cul- 
tured  in  the presence of PDGF was  inhibited  in  a  dose- 
dependent manner by addition of increasing concentratiotas 
of recombinant TGF-~I,  with half-maximal inhibition ob- 
served upon addition of 1 ng/ml (Fig. 7 a). DNA synthesis 
was  also  inhibited  by  addition  of both  nonacidified  and 
acidifed OG-CM (Fig. 7 b). The level of inhibition observed 
with acidified CM (2-, Fig. 7 b) was approximately twice 
that seen with nonacidified CM (1-, Fig. 7 b). The inhibi- 
tory activity of nonacidified CM was not affected by preincu- 
bation with TGF-fl antibodies (2 +, Fig. 7 b), while the in- 
hibitory activity of acidified CM was decreased to a level 
equivalent to nonacidified CM by preincubation with these 
antibodies (2+,  Fig. 7 b). 
TGF-/~ also affected the rate at which O-2A progenitor 
ceils differentiated into oligodendrocytes in the presence of 
PDGF, as measured by emergence of the oligodendrocyte- 
specific differentiation marker GC. After 48 h  in the pres- 
ence of PDGF, 38% of O-2A cells which were labeled with 
the 04 antibody had the characteristic branched morphology 
of differentiated oligodendrocytes and were labeled with the 
monoclonal antibody RmAb (Fig.  8, A and B). After 48 h 
in PDGF plus TGF-/5'I, in contrast, 62 % of 04+ cells were 
also  RmAb  + (Fig.  8,  C  and D).  Similar results were ob- 
tained using the anti-GC antibody O1  (data not shown). In 
the  presence  of PDGF,  O-2A  progenitor  cells  (04+GC- 
cells) had a  predominantly bipolar morphology with long 
processes  (Fig.  8  A,  arrows), characteristic  of  PDGF- 
induced migratory cells  (McKinnon et al.,  1993).  In the 
presence of PDGF and TGF-~I,  in contrast,  the O4+GC - 
cells had a multibranched appearance of nonmigratory ceils 
(Fig. 8 C, arrows), suggesting that TGF-/3 also prevented the 
PDGF-induced motility of these cells. 
We examined whether the TGF-/3s produced by O-2A cells 
inhibited the PDGF-driven proliferation of these cells. O-2A 
progenitor cells were cultured in media containing PDGF, 
in either the presence or absence of TGF-/~ neutralizing anti- 
bodies,  and  thymidine  incorporation was  measured  after 
72 h (Table m). In the absence of TGF-/~ antibodies, thymi- 
dine  incorporation  in  PDGF-containing  cultures  was  re- 
duced relative to bFGF-treated cultures, indicating that the 
cells were exiting the cell cycle and beginning to differentiate 
(Table HI). Addition of TGF-# antibodies to PDGF-treated 
cultures increased the level of DNA synthesis to levels seen 
with bFGF (Table I/I). These antibodies also increased the 
level of DNA synthesis in O-2A cultures in the absence of 
mitogens, but had no significant effect on cultures incubated 
in the presence of bFGF (Table Ill).  These results suggest 
that the latent forms of TGF-/~ secreted by O-2A cells (Figs. 
6 and 7 b) are biologically activated in these cultures, as de- 
termined  in  a  72 h  differentiation assay  (Table HI).  The 
mechanism by which these molecules are activated in this 
Figure 7. Inhibition of PDGF-driven proliferation 
of primary  rat  O-2A  glial  progenitor  cells  by 
recombinant TGF-fl (A) and by oligodendrocyte- 
conditioned  medium  (B).  (,4) Incorporation  of 
[3H]thymidine into  O-2A  progenitor  ceils  cul- 
tured for 24 h in the presence of  5 ng/ml PDGF-AA 
(open symbols) or 5 ng/ml bFGF (closed  symbols), 
with  increasing  concentrations  of  recombinant 
TGF-~I. Values represent the  mean  ±  SEM of 
triplicate samples from three independent assays. 
100% incorporation for PDGF represents 11,632 
+  571 cpm, and for bFGF represents 12,100 + 
247 cpm. (B) Thymidine incorporation in O-2A 
cells cultured in the presence of nonacidified (/) 
or  acidified  (2)  oligodendrocyte-conditioned 
medium (75 % vol), with (+) or without (-) prein- 
cubation with rabbit anti-TGF-fl neutralizing an- 
tisera. Values  expressed as % control represent the 
mean + SEM of  triplicate samples, representative 
of two assays, and 100% incorporation in control 
cultures (0) represents 3,903 ±  244 cpm. 
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TGF-[3 Neutralizing Antibodies 
Thymidine incorporation 
(% control) 
-  Antibody  + Antibody 
No mitogen  50.7  +  16.0  90.0  +  3.6 
bFGF  100.0  +  13.0  113.4  +  14.6 
PDGF-AA  78.1  +  11.3  107.1  +  10.4 
bFGF+PDGF  111.7  +  12.9  106.8  +  15.4 
Proliferation of O-2A progenitor cells in the presence and absence of TGF-/3 
neutralizing antisera. Results are expressed as the mean ±  SEM of [3H]thymi- 
dine incorporation in triplicate samples, representative of three independent as- 
says, and are expressed as percent of control incorporation  (in media containing 
bFGF) in absence of CM (4,640  +  604 cpm). 
Figure 8. Immunocytochemical  analysis  of  O-2A cells under differ- 
ent culture conditions. Cultures were stained with monoclonal  anti- 
bodies recognizing antigens present on O-2A progenitor cells (04 
antibody, left panels) and differentiated oligodendrocytes  (RmAb, 
right panels). Cells were cultured for 48 h in control medium con- 
taining 5 ng/ml PDGF-AA  (A and B) or PDGF plus 2 ng/ml TGF-B1 
(C and D). In the presence of PDGF, O-2A progenitor (RmAb-) 
cells had a predominantly bipolar morphology (A, arrow), while 
in the presence of TGF-~I plus PDGF, these cells had a highly 
branched morphology (C, arrow). Bar, 20/~M. 
system remains to be elucidated. Thus, TGF-~ produced by 
O-2A lineage cells may limit their proliferative response to 
PDGE 
Our results also suggest that bFGF may counteract the in- 
hibitory effects of TGF-B on cell proliferation. Recombinant 
TGF-/~I  was  less  potent in inhibiting the proliferation of 
O-2A progenitor cells cultured in the presence ofbFGF (Fig. 
7 a). At 2 ng/ml TGF-I~I, bFGF-driven mitosis was inhibited 
by 20% relative to control values, while PDGF-driven mito- 
sis was inhibited by 55 % (Fig. 7 a). bFGF also decreased 
the growth inhibitory effect of TGF-~I on CCL-64 cells; in 
the presence  of PDGF-AA  (or  PDGF-BB),  TGF-/31 gave 
50%  inhibition of proliferation at 250 pg/mi, while in the 
presence of bFGF comparable inhibition required a fourfold 
higher concentration (1 ng/ml) of TGF-~. Thus, bFGF at- 
tenuated the growth inhibitory effects  of TGF-~I, both in 
CCL-64 epithelial cells and in primary O-2A glial progeni- 
tor cells. 
Discussion 
We have demonstrated that O-2A lineage cells express tran- 
scripts encoding specific isoforms of TGF-/~, are immuno- 
reactive with anti-TGF-B antibodies, and secrete into their 
culture medium a growth inhibitory activity which is neu- 
tralizable with anti-TGF-/3 antisera. O-2A progenitor cells 
produce TGF-/5'I, and as these cells differentiate into oligo- 
dendrocytes, we observed a relative increase in latent forms 
of TGF-/3, the emergence of TGF-/~2 and TGF-/33 transcripts 
and immunoreactive protein, and a decrease in the levels of 
a second uncharacterized inhibitory activity. Further, both 
recombinant TGF-/~ and TGF-/~ produced by O-2A cultures 
inhibits the proliferation of O-2A progenitor cells and pro- 
motes  oligodendrocyte differentiation.  This  inhibition  of 
proliferation is 2.5-fold greater when O-2A progenitors are 
cultured in the presence of PDGF than in the presence of 
bFGE Our results suggest that TGF-/3 produced by O-2A lin- 
eage cells could have autocrine (self) or paracrine (neigh- 
boring cells) inhibitory effects to limit the number of mitosis 
occurring in O-2A progenitor cells cultured in the presence 
of PDGE 
Our data indicate that the majority of the growth-inhibi- 
tory activity in O-2A progenitor cell conditioned medium 
represents a latent form of TGF-/3. The lowest level of neu- 
tralization we obtained with anti-TGF-fl antisera eliminated 
~50% of the CCL-64 inhibitory activity in O2A-CM (Table 
I). The remaining activity could represent a form of TGF-~ 
not  recognized  by  antibodies  raised  against  recombinant 
TGF-fl, or a distinct (non-TGF-fl) inhibitory molecule. This 
second inhibitory component did not require acidification in 
order to be active in the CCL-64 growth inhibition assay, and 
its levels  were substantial in O-2A progenitor cell condi- 
tioned medium and were reduced as these cells differentiated 
into oligodendrocytes (Fig. 6). This second activity has not 
been further characterized. 
Oligodendrocyte cultures  secreted  predominantly latent 
forms of TGF-/~, which required transient acidification in or- 
der to be detected in the CCL-64 assay.  Since the TGF-/~s 
produced during oligodendrocyte differentiation could be 
neutralized with TGF-/3 antibodies (Table III), O-2A lineage 
cells may be capable of activating the latent forms of TGF-/~ 
produced in this culture system. The process whereby latent 
TGF-~ is activated is not well understood, although there is 
evidence that plasminogen activator may be involved (Flau- 
menhaft et al.,  1992).  The role of other neuronal and glial 
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cells remains to be determined. 
Levi et al.  (1991) have reported that O-2A conditioned 
medium contains a high molecular mass (>30 kDa) factor 
capable of inducing oligodendrocyte  differentiation. Louis et 
al. (1992b) have also described a growth inhibitory activity 
produced by CG-4 cells, a rat CNS cell line with the pheno- 
typic properties  of O-2A  progenitor cells  (Louis et  al., 
1992a). Similarly, the myelin-forming Schwann cells of the 
peripheral nervous system secrete a growth-inhibitory activ- 
ity which may be a proteolytic fragment of fibronectin (Muir 
et al., 1990; Muir and Manthorpe, 1992). Thus, TGF-/3 may 
be only one of several molecules acting in an autocrine man- 
ner to regulate the growth of myelin-forming cells. 
While both bFGF and PDGF promote O-2A proliferation, 
only bFGF  can  sustain this proliferation and thus block 
differentiation (McKinnon et al.,  1990).  In the presence of 
PDGE these cells undergo only a limited number of mitosis 
before differentiation, referred to as a PDGF-driven molecu- 
lar "clock" (Raft et al., 1988).  It has been proposed that this 
represents the dilution of some critical intracellular molecule 
in the PDGF signal transduction pathway (Temple and Raft, 
1986;  Raft et al., 1988; Raft, 1989).  The ability of TGF-/31 
to inhibit the PDGF-driven mitosis of O-2A progenitor cells 
(Fig. 7) suggests that cell-extrinsic factors may also limit the 
proliferative response of these cells to PDGE  TGF-/3 also 
appeared to inhibit the effects of PDGF on cell motility, as 
determined by the absence of  bipolar motile cells in the pres- 
ence of both PDGF and TGF-/31 (Fig. 8 c). TGF-/3 can nega- 
tively regulate the expression of PDGF alpha-receptors in 
other  cell types (Gronwald et al.,  1989;  Battegay et al., 
1990).  Thus, O-2A progenitor cells may also downregulate 
PDGF alpha-receptor expression in response to TGF-/~. 
If the limited proliferation of O-2A progenitor cells in the 
presence of PDGF is due to either autocrine or paracrine 
effects  of TGF-/3, then their extended proliferation in the 
presence of bFGF may interfere with either the production 
of TGF-/$ or the ability of TGF-/3 to inhibit their prolifera- 
tion. Our results suggest that bFGF did not affect the expres- 
sion or release of TGF-~I by O-2A progenitor cells. How- 
ever, the inhibitory effects of TGF-/~ were attenuated in the 
presence of bFGF, for both O-2A progenitor cells (Fig. 7 a) 
and for CCL-64 mink lung epithelial cells. Thus, one mech- 
anism by which bFGF blocks O-2A progenitor cell differen- 
tiation (McKinnon et al.,  1990)  may be to interfere with 
a  TGF-/3-mediated pathway of oligodendrocyte differenti- 
ation. 
Antagonistic effects for bFGF and TGF-/$ have been de- 
scribed in several systems, and may be a general feature of 
vertebrate development. For example,  TGF-/~ inhibits the 
bFGF-induced commitment of neural-crest cells to melano- 
genesis (Stocker et al.,  1991). TGF-/3 also inhibits bFGF- 
induced endothelial cell proliferation, migration, and pro- 
duction of plasminogen activator (Baird and Durkin, 1986; 
Frhter-Schr6der et al., 1986;  Heimark et al., 1986;  Miiller 
et al.,  1987; Saksela et al.,  1987) through a complex loop 
in which plasminogen activator leads to the activation of la- 
tent TGF-/$, which in turn inhibits plasminogen activator 
(Flaumenhaft et al., 1992).  FGF and TGF-/3 may also have 
synergistic effects in some developmental systems, such as 
in mesoderm induction (Kimelman and Kirschner,  1987). 
Another mechanism by which bFGF and TGF-/$ have an- 
tagonistic  effects  could be  through  receptor  modulation. 
Both ligands bind with high affinity to specific transmem- 
brahe  receptors  with intrinsic tyrosine (FGF)  or  serine- 
threonine (TGF-/3) kinase activity (Aaronson,  1991; Lin et 
al.,  1992;  Ullrich and Schlessinger,  1990),  as well as to 
lower  affinity receptors  (Massagu6,  1992;  Yayon et  al., 
1991).  The  type HI  TGF-/$ receptor  betaglycan (Ltpez- 
Casillas et al.,  1991; Massagut,  1992;  Wang et al.,  1991; 
Yayon et al.,  1991) can also bind bFGF (Ltpez-Casillas et 
al.,  1991), and bFGF downregulates one TGF-/3 receptor 
subtype on endothelial cells (Fafeur et al., 1990).  Thus, the 
antagonistic effects of  bFGF and TGF-/3 on O-2A progenitor 
cells could also result from receptor downregulation. 
Our in vitro studies suggest a role for TGF-/3 in the devel- 
opment of the myelin-forming cells in the CNS. The finding 
that TGF-/~2 and TGF-/~3 are present in the developing CNS 
(Flanders et al., 1991; Unsicker et al., 1991) provides sup- 
port for this postulate. Whether any of  these factors influence 
oligodendrocyte development in vivo remains to be eluci- 
dated.  If TGF-/3 is produced by oligodendrocytes and/or 
their precursors in vivo, this would support the concept of 
an internally timed cell autonomous regulatory mechanism 
that limits the proliferation and controls the differentiation 
of these cells in vivo. However, the observations that TGF-/~ 
is present in neurons (Flanders et al.,  1991) would suggest 
that the interaction of oligodendrocyte precursor cells with 
their axonal targets could also be a key regulatory step in the 
cascade of events initiating oligodendrocyte differentiation. 
Our studies further indicate that a hierarchy ofpolypeptide 
growth factors influence the proliferation and rate of dif- 
ferentiation of O-2A glial progenitor cells in culture. TGF-/~ 
suppresses the mitogenic stimulus of PDGF, limiting the ex- 
tent of PDGF-driven proliferation and allowing differentia- 
tion. In contrast, bFGF limits the inhibitory effects of TGF-/~ 
and allows sustained proliferation, preventing the cells from 
differentiating. Inherent in these observations is the principle 
that the context of growth factor presentation (Nathan and 
Sporn,  1991; Roberts and Sporn,  1990)  greatly influences 
their biological effects on the cells under study. 
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